Published October 3, 2018
| Version v1
Journal article
Open
ACVR1 and TGFBR1 purification, and composite screen design
Description
Purification of ACVR1 as well as TGFBR1, and design of a super screen for ACVR1
Notes
The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA Darmstadt Germany, MSD, Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome [106169/ZZ14/Z].
Files
Files
(9.9 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:d6facd546a4d7af2bad55fbf2ff8ea24
|
20.3 kB | Download |
|
md5:9050a9630936aaa69e8f6fce3dbb4761
|
8.8 MB | Download |
|
md5:fec99fbc319b25a8ce5304043813c533
|
1.1 MB | Download |